Clinical Trial Update: An Assessment of the Ability of Fentanyl Citrate Nasal Spray to Manage Breakthrough Pain in Cancer Patients. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating fentanyl citrate nasal spray for breakthrough pain in cancer patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Fentanyl Citrate Nasal Spray (fentanyl citrate nasal spray)

Snippet

Sponsor: University of Louisville | Conditions: Pain | Phase 4 | Status: WITHDRAWN